Los Angeles Capital Management’s West Pharmaceutical WST Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $15.2M | Buy |
60,705
+17,794
| +41% | +$4.43M | 0.06% | 211 |
|
|
2025
Q4 | $12M | Buy |
42,911
+5,970
| +16% | +$1.63M | 0.04% | 218 |
|
|
2025
Q3 | $9.69M | Buy |
36,941
+25,707
| +229% | +$6.25M | 0.03% | 269 |
|
|
2025
Q2 | $2.46M | Buy |
+11,234
| New | +$2.4M | 0.01% | 417 |
|
|
2023
Q4 | – | Sell |
-10,208
| Closed | -$3.83M | – | 1252 |
|
|
2023
Q3 | $3.83M | Sell |
10,208
-118,862
| -92% | -$46M | 0.02% | 346 |
|
|
2023
Q2 | $49.4M | Sell |
129,070
-10,964
| -8% | -$3.92M | 0.2% | 105 |
|
|
2023
Q1 | $48.5M | Buy |
140,034
+136,586
| +3,961% | +$39.9M | 0.22% | 108 |
|
|
2022
Q4 | $811K | Sell |
3,448
-5,879
| -63% | -$1.39M | ﹤0.01% | 763 |
|
|
2022
Q3 | $2.29M | Sell |
9,327
-3,698
| -28% | -$1.13M | 0.01% | 474 |
|
|
2022
Q2 | $3.94M | Sell |
13,025
-5,392
| -29% | -$1.75M | 0.02% | 399 |
|
|
2022
Q1 | $7.56M | Sell |
18,417
-13,987
| -43% | -$5.48M | 0.03% | 304 |
|
|
2021
Q4 | $15.2M | Buy |
32,404
+5,323
| +20% | +$2.29M | 0.06% | 237 |
|
|
2021
Q3 | $11.5M | Buy |
27,081
+927
| +4% | +$391K | 0.05% | 253 |
|
|
2021
Q2 | $9.39M | Buy |
26,154
+174
| +0.7% | +$57.5K | 0.04% | 304 |
|
|
2021
Q1 | $7.32M | Sell |
25,980
-73,990
| -74% | -$21.2M | 0.03% | 347 |
|
|
2020
Q4 | $28.3M | Sell |
99,970
-51,956
| -34% | -$14.6M | 0.12% | 158 |
|
|
2020
Q3 | $41.8M | Buy |
151,926
+474
| +0.3% | +$125K | 0.19% | 111 |
|
|
2020
Q2 | $34.4M | Buy |
151,452
+22,807
| +18% | +$4.48M | 0.17% | 134 |
|
|
2020
Q1 | $19.6M | Sell |
128,645
-15,467
| -11% | -$2.38M | 0.12% | 166 |
|
|
2019
Q4 | $21.7M | Buy |
144,112
+2,550
| +2% | +$371K | 0.11% | 183 |
|
|
2019
Q3 | $20.1M | Buy |
141,562
+78,148
| +123% | +$10.8M | 0.11% | 188 |
|
|
2019
Q2 | $7.94M | Buy |
63,414
+3,930
| +7% | +$464K | 0.04% | 351 |
|
|
2019
Q1 | $6.55M | Buy |
59,484
+1,840
| +3% | +$191K | 0.04% | 382 |
|
|
2018
Q4 | $5.65M | Sell |
57,644
-21,180
| -27% | -$2.3M | 0.04% | 357 |
|
|
2018
Q3 | $9.73M | Sell |
78,824
-275
| -0.3% | -$30.8K | 0.05% | 341 |
|
|
2018
Q2 | $7.85M | Sell |
79,099
-5,220
| -6% | -$481K | 0.04% | 403 |
|
|
2018
Q1 | $7.45M | Sell |
84,319
-34,105
| -29% | -$3.19M | 0.04% | 373 |
|
|
2017
Q4 | $11.7M | Sell |
118,424
-1,290
| -1% | -$126K | 0.06% | 311 |
|
|
2017
Q3 | $11.5M | Sell |
119,714
-1,540
| -1% | -$139K | 0.07% | 288 |
|
|
2017
Q2 | $11.5M | Buy |
+121,254
| New | +$11.2M | 0.07% | 290 |
|
|
2016
Q4 | – | Sell |
-25,348
| Closed | -$1.89M | – | 1248 |
|
|
2016
Q3 | $1.89M | Sell |
25,348
-905
| -3% | -$71.8K | 0.02% | 585 |
|
|
2016
Q2 | $1.99M | Sell |
26,253
-265
| -1% | -$19.3K | 0.02% | 541 |
|
|
2016
Q1 | $1.84M | Sell |
26,518
-840
| -3% | -$50.5K | 0.02% | 481 |
|
|
2015
Q4 | $1.65M | Hold |
27,358
| – | – | 0.02% | 547 |
|
|
2015
Q3 | $1.48M | Hold |
27,358
| – | – | 0.01% | 603 |
|
|
2015
Q2 | $1.59M | Sell |
27,358
-2,920
| -10% | -$163K | 0.01% | 619 |
|
|
2015
Q1 | $1.82M | Sell |
30,278
-6,000
| -17% | -$320K | 0.02% | 582 |
|
|
2014
Q4 | $1.93M | Sell |
36,278
-1,270
| -3% | -$63.5K | 0.02% | 495 |
|
|
2014
Q3 | $1.68M | Sell |
37,548
-90
| -0.2% | -$3.82K | 0.02% | 476 |
|
|
2014
Q2 | $1.59M | Buy |
37,638
+3,335
| +10% | +$143K | 0.02% | 557 |
|
|
2014
Q1 | $1.51M | Sell |
34,303
-23,815
| -41% | -$1.12M | 0.02% | 551 |
|
|
2013
Q4 | $2.85M | Buy |
58,118
+48,640
| +513% | +$2.28M | 0.03% | 433 |
|
|
2013
Q3 | $390K | Buy |
9,478
+100
| +1% | +$3.81K | ﹤0.01% | 1003 |
|
|
2013
Q2 | $329K | Buy |
+9,378
| New | +$309K | ﹤0.01% | 1045 |
|
Other funds holding WST
VCM
VPM
GIM
Los Angeles Capital Management's WST Position: Q1 2026 in Review
Los Angeles Capital Management increased its West Pharmaceutical (WST) stake by 41% in Q1 2026, buying an estimated $4.43M and bringing the position to 60,705 shares worth $15.2M. The position accounts for 0.06% of the portfolio, ranked #211.
Los Angeles Capital Management first reported a position in WST in Q2 2013 and has held it in 44 quarters since. The position peaked at $49.4M in Q2 2023. 753 funds tracked by Wall St. Rank hold WST as of Q1 2026.
- Los Angeles Capital Management held 60,705 shares of West Pharmaceutical worth $15.2M as of Q1 2026.
- Los Angeles Capital Management bought 17,794 West Pharmaceutical shares in Q1 2026, an estimated $4.43M.
- West Pharmaceutical made up 0.06% of Los Angeles Capital Management's portfolio in Q1 2026, its #211 holding.
- Los Angeles Capital Management first reported a position in West Pharmaceutical in Q2 2013 and has held it in 44 quarters since.
- Los Angeles Capital Management's West Pharmaceutical position peaked at $49.4M in Q2 2023.
- 753 funds tracked by Wall St. Rank held West Pharmaceutical as of Q1 2026.
Based on Los Angeles Capital Management's 13F filing for Q1 2026, filed 8 May 2026.